Liechti ME - Search Results

1

Effects of methylphenidate and MDMA on appraisal of erotic stimuli and intimate relationships.

Schmid Y, Hysek CM, Preller KH, Bosch OG, Bilderbeck AC, Rogers RD, Quednow BB, Liechti ME. Schmid Y, et al. Among authors: liechti me. Eur Neuropsychopharmacol. 2015 Jan;25(1):17-25. doi: 10.1016/j.euroneuro.2014.11.020. Epub 2014 Dec 4. Eur Neuropsychopharmacol. 2015. PMID: 25498417 Free article. Clinical Trial.

2

Psychological and cardiovascular effects and short-term sequelae of MDMA ("ecstasy") in MDMA-naïve healthy volunteers.

Vollenweider FX, Gamma A, Liechti M, Huber T. Vollenweider FX, et al. Neuropsychopharmacology. 1998 Oct;19(4):241-51. doi: 10.1016/S0893-133X(98)00013-X. Neuropsychopharmacology. 1998. PMID: 9718588 Clinical Trial.

3

Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram.

Liechti ME, Baumann C, Gamma A, Vollenweider FX. Liechti ME, et al. Neuropsychopharmacology. 2000 May;22(5):513-21. doi: 10.1016/S0893-133X(99)00148-7. Neuropsychopharmacology. 2000. PMID: 10731626 Clinical Trial.

4

Acute psychological and physiological effects of MDMA ("Ecstasy") after haloperidol pretreatment in healthy humans.

Liechti ME, Vollenweider FX. Liechti ME, et al. Eur Neuropsychopharmacol. 2000 Jul;10(4):289-95. doi: 10.1016/s0924-977x(00)00086-9. Eur Neuropsychopharmacol. 2000. PMID: 10871712 Clinical Trial.

5

3,4-Methylenedioxymethamphetamine (MDMA) modulates cortical and limbic brain activity as measured by [H(2)(15)O]-PET in healthy humans.

Gamma A, Buck A, Berthold T, Liechti ME, Vollenweider FX. Gamma A, et al. Among authors: liechti me. Neuropsychopharmacology. 2000 Oct;23(4):388-95. doi: 10.1016/S0893-133X(00)00130-5. Neuropsychopharmacology. 2000. PMID: 10989265 Clinical Trial.

6

Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans.

Liechti ME, Saur MR, Gamma A, Hell D, Vollenweider FX. Liechti ME, et al. Neuropsychopharmacology. 2000 Oct;23(4):396-404. doi: 10.1016/S0893-133X(00)00126-3. Neuropsychopharmacology. 2000. PMID: 10989266 Clinical Trial.

7

Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin.

Liechti ME, Geyer MA, Hell D, Vollenweider FX. Liechti ME, et al. Neuropsychopharmacology. 2001 Mar;24(3):240-52. doi: 10.1016/S0893-133X(00)00199-8. Neuropsychopharmacology. 2001. PMID: 11166515

8

Gender differences in the subjective effects of MDMA.

Liechti ME, Gamma A, Vollenweider FX. Liechti ME, et al. Psychopharmacology (Berl). 2001 Mar 1;154(2):161-8. doi: 10.1007/s002130000648. Psychopharmacology (Berl). 2001. PMID: 11314678 Clinical Trial.

9

Effects of a beta-blocker on the cardiovascular response to MDMA (Ecstasy).

Hysek CM, Vollenweider FX, Liechti ME. Hysek CM, et al. Among authors: liechti me. Emerg Med J. 2010 Aug;27(8):586-9. doi: 10.1136/emj.2009.079905. Epub 2010 Apr 8. Emerg Med J. 2010. PMID: 20378736 Free article. Clinical Trial.

10

The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA ("ecstasy") in humans.

Hysek CM, Simmler LD, Ineichen M, Grouzmann E, Hoener MC, Brenneisen R, Huwyler J, Liechti ME. Hysek CM, et al. Among authors: liechti me. Clin Pharmacol Ther. 2011 Aug;90(2):246-55. doi: 10.1038/clpt.2011.78. Epub 2011 Jun 15. Clin Pharmacol Ther. 2011. PMID: 21677639 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

244 results

Search Page

Filters